Thoracic Imaging 2003 - Society of Thoracic Radiology
Thoracic Imaging 2003 - Society of Thoracic Radiology
Thoracic Imaging 2003 - Society of Thoracic Radiology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
TUESDAY<br />
182<br />
Workshop A1: Lymphoma: Spectrum <strong>of</strong> Disease<br />
Kitt Shaffer, M.D., Ph.D.<br />
Assistant Chief <strong>of</strong> <strong>Radiology</strong>, Dana-Farber Cancer Institute<br />
Introduction and Objectives<br />
Lymphoma is actually a very heterogeneous collection <strong>of</strong><br />
disorders that can have a wide variety <strong>of</strong> clinical appearance and<br />
imaging features. In general, lymphomas are classified into<br />
either Hodgkin’s disease (HD) or non-Hodgkin’s lymphoma<br />
(NHL). In both HD and NHL, the chest is a very frequent site<br />
<strong>of</strong> involvement but the pattern <strong>of</strong> disease differs slightly<br />
between the two disorders. In terms <strong>of</strong> incidence, HD and NHL<br />
together make up about 5 percent <strong>of</strong> all newly diagnosed cancers<br />
and about 5 percent <strong>of</strong> all cancer deaths. The incidence <strong>of</strong><br />
HD is similar to that <strong>of</strong> primary sarcomas while the incidence <strong>of</strong><br />
NHL is similar to that <strong>of</strong> pancreatic cancer. Both are much less<br />
common that lung cancer. This workshop will review some<br />
general principles <strong>of</strong> imaging <strong>of</strong> HD and NHL and will introduce<br />
the complex topic <strong>of</strong> NHL classification, which is constantly<br />
evolving as our understanding <strong>of</strong> the mechanisms <strong>of</strong> disease<br />
expand. A brief review <strong>of</strong> some <strong>of</strong> the expected imaging<br />
findings after treatment <strong>of</strong> lymphoma will also be presented.<br />
After completing this workshop, participants should be more<br />
familiar with typical and atypical imaging features <strong>of</strong> HD,<br />
should be more aware <strong>of</strong> the various subtypes <strong>of</strong> NHL and some<br />
<strong>of</strong> the newer categories based on immunophenotyping and genetic<br />
analysis, and should be able to recognize common treatment<br />
effects and complications <strong>of</strong> treatment <strong>of</strong> both HD and NHL.<br />
Hodgkin’s disease<br />
The typical appearance <strong>of</strong> thoracic disease in HD is an anterior<br />
mediastinal mass without calcification or necrosis. Unlike<br />
NHL, HD tends to spread contiguously, involving adjacent<br />
nodal groups in an orderly manner. Lung involvement at diagnosis<br />
is not uncommon in HD, but is always present in lung<br />
adjacent to a hilar mass, indicating contiguous spread. Lung<br />
involvement may be difficult to distinguish from atelectasis on<br />
imaging studies. The commonest nodal groups involved by<br />
NHL are first the anterior mediastinum followed by the right<br />
paratracheal nodes and hilar nodes. Atypical appearances are<br />
also possible in HD, and may include SVC syndrome, necrosis,<br />
and calcification pre-treatment. Calcification in masses after<br />
treatment are common.<br />
Non-Hodgkins lymphoma<br />
The imaging appearance <strong>of</strong> NHL is much more varied than<br />
HD. Nodal involvement may <strong>of</strong>ten be discontinuous and overall<br />
lung involvement is more common. Prognosis for NHL is also<br />
worse than HD although there is a wide range from indolent<br />
forms to more aggressive forms. In general, the indolent subtypes<br />
are harder to cure but survival times are longer. The more<br />
aggressive forms may kill the patient quickly but actually have<br />
the best chance <strong>of</strong> long-term cure as most treatment modalities<br />
(radiation and chemotherapy) depend on rapidly dividing cells,<br />
which are seen in the more aggressive cell types.<br />
Classification <strong>of</strong> NHL is a particularly complex topic and is<br />
in constant flux. Many different systems have been used in the<br />
past, most depending on histologic appearance <strong>of</strong> cells. More<br />
current methods, such as the REAL classification system which<br />
will be used in this presentation, attempt to integrate histology<br />
with immunophenotype to approach a more pathophysiologically<br />
based approach to classification. Some subtypes <strong>of</strong> NHL<br />
(diffuse large cell, follicular, MALT) were well known from<br />
prior systems but other subtypes (mantle cell, anaplastic large<br />
cell, mediastinal large cell) are relatively new. Most <strong>of</strong> these<br />
newer subtypes depend for diagnosis on either immunophenotyping<br />
or genetic analysis, which were not included in older<br />
classification systems.<br />
Categories <strong>of</strong> NHL<br />
Certain subtypes <strong>of</strong> NHL are so characteristic in histologic<br />
appearance that they were well described and consistently diagnosed<br />
even before the introduction <strong>of</strong> complex classifications<br />
involving immunohistochemistry and cytogenetics. Among<br />
these subtypes are diffuse large cell NHL, follicular NHL and<br />
mucosal-associated lymphomas. Other subtypes are <strong>of</strong> more<br />
recent origin, depending on more elaborate evaluations including<br />
immunohistochemistry or analysis for genetic markers and specific<br />
translocations. This includes anaplastic large cell NHL, mediastinal<br />
large cell NHL, T-cell rich B-cell NHL and mantle NHL.<br />
Diffuse large cell NHL is one <strong>of</strong> the more common subtypes<br />
<strong>of</strong> NHL, and in the past probably included a very heterogeneous<br />
group <strong>of</strong> disorders, some <strong>of</strong> which are now better discriminated<br />
and reclassified into other categories, such as anaplastic large<br />
cell or mantle cell NHL. Diffuse large cell NHL <strong>of</strong>ten involves<br />
the chest and may include both nodal and extranodal disease. It<br />
is typical <strong>of</strong> aggressive or high-grade NHL, which can have a<br />
precipitous course, but is therefore <strong>of</strong>ten more responsive to<br />
treatment and more amenable to cure. Most are <strong>of</strong> B-cell origin,<br />
with about 20% demonstrating T-cell phenotype.<br />
Follicular NHL is the prototype <strong>of</strong> indolent, low-grade lymphoma.<br />
It is very difficult to cure, but patients may survive with<br />
their disease for many years. Follicular NHL generally is restricted<br />
to nodal disease and <strong>of</strong>ten has discontinuous involvement <strong>of</strong><br />
many nodal groups. Nodes may be small or bulky. If a particular<br />
node or group <strong>of</strong> nodes suddenly enlarges, the possibility <strong>of</strong> transformation<br />
to a higher grade tumor must be considered.<br />
Lymphomas <strong>of</strong> the mucosal-associated lymphoid tissues<br />
(MALT) have been well-known for some time and are generally<br />
<strong>of</strong> the indolent variety. Most are <strong>of</strong> B-cell origin and most <strong>of</strong>ten<br />
involve the lungs, stomach, salivary glands and lacrimal glands.<br />
Almost any organ has been reported to give rise to MALT-like<br />
lymphomas, including the bladder, the kidney, the uterus, breast,<br />
and the thymus. Marginal zone lymphomas are neoplasms <strong>of</strong><br />
similar cell type occurring in nodes, involving the marginal<br />
regions which surround germinal centers.<br />
Anaplastic large cell NHL is a relatively recently described<br />
category <strong>of</strong> NHL in which the neoplastic cells express the Ki-1<br />
antigen, CD30. This same antigen is found on Reed-Sternberg<br />
cells <strong>of</strong> HD as well as in activated T and B-cells. A characteristic<br />
translocation is also usually present except in the cutaneous<br />
form. Skin, lung and nodal involvement are common and the<br />
course is <strong>of</strong>ten aggressive.<br />
Mediastinal large cell NHL is a subtype <strong>of</strong> large cell NHL<br />
that occurs specifically in the mediastinum and has a more<br />
aggressive course. Tumor masses <strong>of</strong>ten contain considerable<br />
sclerosis and the appearance can easily be mistaken for HD on<br />
imaging, although signs <strong>of</strong> aggressive behavior, such as necrosis,<br />
superior vena cava compression, and chest wall invasion, are<br />
more commonly seen than in HD.